alpha-Cyperone
CAS No. 473-08-5
alpha-Cyperone( α-Cyperone | (+)-α-Cyperone )
Catalog No. M18587 CAS No. 473-08-5
Alpha-Cyperone is a promising inhibitor of Hla production by S. aureus and protects lung cells from this bacterium.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 25MG | 143 | In Stock |
|
| 50MG | 215 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namealpha-Cyperone
-
NoteResearch use only, not for human use.
-
Brief DescriptionAlpha-Cyperone is a promising inhibitor of Hla production by S. aureus and protects lung cells from this bacterium.
-
DescriptionAlpha-Cyperone is a promising inhibitor of Hla production by S. aureus and protects lung cells from this bacterium. Alpha-Cyperone significantly inhibited PGE2 production by suppressing the LPS-induced expression of inducible COX-2 at both the mRNA and the protein levels , downregulated the production and mRNA expression of the inflammatory cytokine IL-6. Alpha-Cyperone inhibited actin cytoskeleton polymerization induced by APEC-O78 through down regulating the expression of Nck-2, Cdc42 and Rac1.
-
In Vitro——
-
In Vivo——
-
Synonymsα-Cyperone | (+)-α-Cyperone
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number473-08-5
-
Formula Weight218.34
-
Molecular FormulaC15H22O
-
Purity>98% (HPLC)
-
SolubilityDMSO : < 1 mg/mL
-
SMILESCC1=C2CC(CCC2(CCC1=O)C)C(=C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Citenamide
Citenamide (AY-15613) has anticancer and anticonvulsant activity and is used in the study of neurological disorders because of its sleep-promoting properties.
-
Momordicin IV
Momordicin IV
-
Beta-Tocotrienol
Beta-Tocotrienol to serve as a new anticancer agent for treating human lung and brain cancers. It inhibits the growth of both A549 (GI50=1.38±0.334μM) and U87MG (GI50=2.53±0.604μM) cells at rather low concentrations.
Cart
sales@molnova.com